HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi-Ching Su Selected Research

Polymers

4/2016In vivo biological response to highly cross-linked and vitamin e-doped polyethylene--a particle-Induced osteolysis animal study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi-Ching Su Research Topics

Disease

8Infections
01/2022 - 06/2013
7Viremia
12/2022 - 06/2014
5HIV Infections (HIV Infection)
09/2021 - 01/2014
5Syphilis
09/2021 - 07/2012
2Reinfection
12/2022 - 10/2019
2Hepatitis B
07/2019 - 01/2016
2Coinfection
07/2019 - 01/2016
2Thyroid Neoplasms (Thyroid Cancer)
10/2018 - 08/2018
2Persistent Infection
01/2016 - 01/2014
2Pneumococcal Infections
01/2016 - 05/2012
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2022
1Pain (Aches)
01/2021
1Chronic Hepatitis B
07/2019
1Cardiovascular Diseases (Cardiovascular Disease)
07/2019
1Neoplasms (Cancer)
08/2018
1Hepatitis A (Hepatitis, Infectious)
01/2017
1Osteolysis
04/2016
1Pneumonia (Pneumonitis)
01/2016
1Tuberculosis (Tuberculoses)
01/2015
1Human Influenza (Influenza)
06/2013
1Conduct Disorder (Conduct Disorders)
01/2006
1Depressive Disorder (Melancholia)
01/2006

Drug/Important Bio-Agent (IBA)

4RNA (Ribonucleic Acid)IBA
12/2022 - 10/2019
4Transaminases (Aminotransferases)IBA
01/2022 - 06/2014
3ReaginsIBA
09/2021 - 01/2014
3Tenofovir (Viread)FDA Link
07/2019 - 06/2014
3Lamivudine (Epivir)FDA Link
07/2019 - 06/2014
2Emtricitabine (Emtriva)FDA Link
01/2022 - 07/2019
2RacivirIBA
01/2022 - 07/2019
2Protease Inhibitors (Protease Inhibitor)IBA
04/2021 - 07/2019
2Lysine (L-Lysine)FDA Link
10/2018 - 08/2018
2Proteins (Proteins, Gene)FDA Link
10/2018 - 08/2018
2Biological ProductsIBA
08/2018 - 04/2016
2Pharmaceutical PreparationsIBA
12/2017 - 01/2016
2Anti-Retroviral Agents (Antiretroviral Agents)IBA
01/2016 - 01/2014
2Conjugate VaccinesIBA
01/2016 - 05/2012
1Antiviral Agents (Antivirals)IBA
12/2022
1elvitegravirIBA
01/2022
1tenofovir alafenamideIBA
01/2022
1CobicistatIBA
01/2022
1Hepatitis C AntibodiesIBA
10/2021
1benzathineIBA
09/2021
1dolutegravirIBA
04/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
07/2020
1Alanine Transaminase (SGPT)IBA
07/2020
1evodiamineIBA
10/2018
1honokiolIBA
08/2018
1PolymersIBA
04/2016
1Polyethylene (Polythene)IBA
04/2016
1ultra-high molecular weight polyethylene (UHMWPE)IBA
04/2016
1Vitamin EFDA LinkGeneric
04/2016
1Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
01/2016
1Zidovudine (Retrovir)FDA LinkGeneric
01/2016
1IntegrasesIBA
01/2016
1abacavir (Ziagen)FDA Link
01/2016
1Interferon-gamma (Interferon, gamma)IBA
01/2015
1DNA (Deoxyribonucleic Acid)IBA
06/2014
1BilirubinIBA
06/2014
1Hepatitis B Surface Antigens (HBsAg)FDA Link
06/2014
1MacrolidesIBA
07/2012
123S Ribosomal RNAIBA
07/2012
1Amphetamine (Amfetamine)FDA LinkGeneric
01/2006

Therapy/Procedure

8Therapeutics
01/2022 - 01/2014
3Highly Active Antiretroviral Therapy (HAART)
07/2019 - 06/2013
2Art Therapy
01/2022 - 04/2021
1Replacement Arthroplasty
04/2016